Literature DB >> 16279584

Transintestinal oxygenation with perfluorocarbon: investigation of perfusion rate.

Kazutoshi Kotani1, Itaru Nagahiro, Hidehiro Nakanishi, Hideaki Mori, Hiroshi Date, Nobuyoshi Shimizu.   

Abstract

OBJECTIVE: Perfluorocarbons are structurally similar to hydrocarbons but with the hydrogen atoms replaced by fluorine. In general, perfluorocarbons have an excellent oxygen and carbon dioxide carrying capacity. We studied the suitability of oxygenated perfluorocarbon as an agent for transintestinal oxygenation and measured its perfusion rates under different conditions. SUBJECTS AND METHODS: We used FC-77 (Sumitomo 3M, Tokyo, Japan) perfluorocarbon and a rat hypoventilation model (room air, 20 breaths/min, a tidal volume of 10 ml/kg). Oxygenated FC-77 was perfused through the small intestine for 4 hours. Rats were allocated to 3 experimental groups according to the perfusion rate and a control group: Group 1 (n=6), 10 ml/min; Group 2 (n=6), 2.5 ml/min; Group 3 (n=6), 0.75 ml/min; Group 4 (n=6) served as a control (hypoventilation only). Arterial blood samples were drawn every 30 minutes. Standard blood gas analysis was performed.
RESULTS: After four hours of perfusion, the PaO2 levels in Groups 1 to 3 were significantly better than Group 4 (p<0.01, Group 1: 141.7 +/- 18.0 mmHg, Group 2: 145.2 +/- 25.1 mmHg, Group 3: 120.5 +/- 21.2 mmHg, Group 4: 67.4 +/- 7.2 mmHg). PaCO2 levels in Groups 1 and 2 were significantly better than Groups 3 and 4 (p<0.01, Group 1: 42.6 +/- 7.2 mmHg, Group 2: 52.1 +/- 7.7 mmHg, Group 3: 78.2 +/- 22.8 mmHg, Group 4: 75.3 +/- 10.3 mmHg).
CONCLUSION: In the present settings, 8 ml/kg/min was adequate for oxygenation and CO2 clearance. This approach promises to become another modality for respiratory assistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16279584     DOI: 10.1007/s11748-005-0064-0

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  13 in total

Review 1.  Liquid ventilation.

Authors:  T H Shaffer; M R Wolfson; L C Clark
Journal:  Pediatr Pulmonol       Date:  1992-10

2.  Cecal enlargement, cardiac output, and O2 consumption in germfree rats.

Authors:  B S Wostmann; E Bruckner-Kardoss; P L Knight
Journal:  Proc Soc Exp Biol Med       Date:  1968-05

Review 3.  Development of an implantable artificial lung: challenges and progress.

Authors:  J B Zwischenberger; C M Anderson; K E Cook; S D Lick; L F Mockros; R H Bartlett
Journal:  ASAIO J       Date:  2001 Jul-Aug       Impact factor: 2.872

4.  Testing of an intrathoracic artificial lung in a pig model.

Authors:  K E Cook; A J Makarewicz; C L Backer; L F Mockros; H J Przybylo; S E Crawford; J M Hernandez; R J Leonard; C Mavroudis
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

5.  Whole body oxygenation using intraperitoneal perfusion of fluorocarbons.

Authors:  N S Faithfull; J Klein; H T van der Zee; P J Salt
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

6.  The effect of age on cardiac output and its distribution in the rat.

Authors:  M S Yates; C R Hiley
Journal:  Experientia       Date:  1979-01-15

7.  The development of an implantable artificial lung.

Authors:  F L Fazzalari; J P Montoya; M R Bonnell; D W Bliss; R B Hirschl; R H Bartlett
Journal:  ASAIO J       Date:  1994 Jul-Sep       Impact factor: 2.872

8.  Treatment of intestinal ischemia with oxygenated intraluminal perfluorocarbons.

Authors:  K T Oldham; K S Guice; D Gore; W K Gourley; T E Lobe
Journal:  Am J Surg       Date:  1987-03       Impact factor: 2.565

9.  Intestinal ischemia: reduction of mortality utilizing intraluminal perfluorochemical.

Authors:  J L Ricci; H A Sloviter; M M Ziegler
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

10.  Major findings from the clinical trials of the intravascular oxygenator.

Authors:  S A Conrad; A Bagley; B Bagley; R N Schaap
Journal:  Artif Organs       Date:  1994-11       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.